A Phase 1 clinical trial using chimeric antigen receptor (CAR) T-cell therapy for pleural mesothelioma tumors shows promise for patients.
The latest treatment for mesothelioma patients combines the power of electric currents with platinum-based chemotherapy drugs.
A new discovery found an anti-mesothelioma antibody that shows sensitivity to detecting and diagnosing mesothelioma symptoms.
Doctors can find evidence of mesothelioma through a blood test. Mesothelioma, however, requires a series of tests for an accurate diagnosis.
Follow part 1 of Allen’s mesothelioma journey from asbestos exposure to life after treatment and learn what led to Allen's diagnosis.
Not all patients experience the same symptoms of mesothelioma as the stage of illness, overall health, and age play significant roles.
Mesothelioma is difficult to diagnose and sometimes misdiagnosed as other forms of cancer. It takes multiple tests to confirm a diagnosis.
Early-stage cancer patients may receive multiple rounds of a single form of mesothelioma treatment or a combination of several types.
We followed Allen’s mesothelioma survivor journey since the first contact with asbestos. Now, we conclude his journey and his survivor story.
The phase II OT-101 clinical trial will study a promising treatment option for patients with pleural mesothelioma.